EXOSOMES THERAPY

No. Exosomes are signaling particles released by cells (including stem cells), but they are not living cells and cannot replicate or become different tissue types. 

Most clinical products are derived from mesenchymal stem cells sourced from tissues such as umbilical cord or placental tissue. The exosomes are collected and purified from these cells in controlled laboratory settings. 

Exosomes are commonly used in regenerative care to support joint health, soft tissue recovery, and overall healing processes. They are often used alongside therapies like PRP or prolotherapy. 

No. Exosome therapies are currently considered investigational and are not FDA-approved for the treatment of specific diseases. 

When sourced and used appropriately, exosome products are generally well tolerated. As with any procedure, there are potential risks, and treatment should be guided by a qualified provider. 

This varies depending on your goals and condition. Some patients use exosomes as part of a single treatment, while others incorporate them into a broader regenerative plan. 

Most patients experience minimal downtime. Some mild soreness or irritation at the treatment site may occur depending on how the therapy is administered.

PRP uses your own blood-derived growth factors, prolotherapy stimulates a healing response using a natural solution like dextrose, and exosomes provide cellular signaling support that may enhance the regenerative environment.